| Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis KN Vokinger, TJ Hwang, T Grischott, S Reichert, A Tibau, T Rosemann, ... The Lancet Oncology 21 (5), 664-670, 2020 | 160 | 2020 |
| Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe KN Vokinger, TJ Hwang, P Daniore, CWC Lee, A Tibau, T Grischott, ... JAMA Oncology 7 (9), e212026-e212026, 2021 | 51 | 2021 |
| Evaluation of the education “Clinical Telemedicine/e-Health” in the curriculum of medical students at the University of Zurich C Brockes, T Grischott, M Dutkiewicz, S Schmidt-Weitmann Telemedicine and e-Health 23 (11), 899-904, 2017 | 47 | 2017 |
| Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in … Y Rachamin, T Grischott, T Rosemann, MR Meyer Atherosclerosis 324, 141-147, 2021 | 23 | 2021 |
| Improving inappropriate medication and information transfer at hospital discharge: study protocol for a cluster RCT T Grischott, S Zechmann, Y Rachamin, S Markun, C Chmiel, O Senn, ... Implementation Science 13 (1), 155, 2018 | 17 | 2018 |
| Chronic obstructive pulmonary disease (COPD) among opioid‐dependent patients in agonist treatment. A diagnostic study T Grischott, L Falcato, O Senn, MA Puhan, P Bruggmann Addiction 114 (5), 868-876, 2019 | 16 | 2019 |
| The Shiny Balancer-software and imbalance criteria for optimally balanced treatment allocation in small RCTs and cRCTs T Grischott BMC Medical Research Methodology 18 (1), 108, 2018 | 12 | 2018 |
| Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study Y Rachamin, L Jäger, R Meier, T Grischott, O Senn, JM Burgstaller, ... Frontiers in Pharmacology 13, 832994, 2022 | 10 | 2022 |
| Implementation of a complex intervention to improve hospital discharge: process evaluation of a cluster randomised controlled trial Y Rachamin, T Grischott, S Neuner-Jehle BMJ Open 11 (5), e049872, 2021 | 8 | 2021 |
| Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study Y Rachamin, S Markun, T Grischott, T Rosemann, R Meier Journal of Clinical Medicine 9 (11), 3719, 2020 | 6 | 2020 |
| What interventions do general practitioners recommend avoiding? A nationwide survey from Switzerland S Neuner-Jehle, T Grischott, S Markun, T Rosemann, O Senn, M Maeder Swiss Medical Weekly 150, w20283, 2020 | 6 | 2020 |
| Medication Review and Enhanced Information Transfer at Discharge of Older Patients with Polypharmacy: a Cluster-Randomized Controlled Trial in Swiss Hospitals T Grischott, Y Rachamin, O Senn, P Hug, T Rosemann, S Neuner-Jehle Journal of General Internal Medicine 38 (3), 610-618, 2023 | 5 | 2023 |
| General practitioners’ consultation counts and associated factors in Swiss primary care–A retrospective observational study Y Rachamin, R Meier, T Grischott, T Rosemann, S Markun PLOS ONE 14 (12), e0227280, 2019 | 5 | 2019 |
| Efficacy of motivating short interventions for smokers in primary care (COSMOS trial): study protocol for a cluster-RCT T Grischott, O Senn, T Rosemann, A Frei, J Cornuz, E Martin-Diener, ... Trials 20 (1), 81, 2019 | 5 | 2019 |
| Medical online consultation service in gastroenterology at the University Hospital Zurich S Schmidt-Weitmann, T Grischott, P Bauerfeind, C Brockes Cogent Medicine 4 (1), 1334409, 2017 | 5 | 2017 |
| Impact of the COVID-19 Pandemic on Elective and Emergency Inpatient Procedure Volumes in Switzerland–A Retrospective Study Based on Insurance Claims Data Y Rachamin, MR Meyer, T Rosemann, T Grischott International Journal of Health Policy and Management 12 (Continuous), 1-9, 2023 | 3 | 2023 |
| Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis Y Rachamin, CJ Ackermann, O Senn, T Grischott PLOS ONE 16 (11), e0259936, 2021 | 2 | 2021 |
| Sample size calculation using Markov chains for a one-arm study of heroin administration routes T Grischott, F Valeri, L Falcato Journal of Biopharmaceutical Statistics, 2021 | 2 | 2021 |
| Importance of different electronic medical record components for chronic disease identification in a Swiss primary care database: a cross-sectional study R Meier, T Grischott, Y Rachamin, L Jäger, O Senn, T Rosemann, ... Swiss Medical Weekly 153 (10), 40107, 2023 | 1 | 2023 |
| Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE … K Weiss, G Pichierri, T Grischott, S Groth, S Neuner-Jehle BMJ Open 13 (9), e075828, 2023 | 1 | 2023 |
Thomas RosemannProfessor of primary care, University of Zurich在 usz.ch 的电子邮件经过验证
